Options Brief: Gen-Probe Incorporated

Shares of Gen-Probe Incorporated GPRO are lower on the session by 13.34%, trading at $70.85. Overall call volume is now running at 6.12x the daily average, with 19% of all calls traded being purchases on the offer. 17,491 contracts have traded on the session so far. Gen-Probe Incorporated is engaged in the development, manufacture and marketing molecular diagnostic products and services, which are used to diagnose human diseases, screen donated human blood, and ensures transplant compatibility.